Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
AVTX
AVTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AVTX News
Avalo Therapeutics Q1 Earnings Beat Expectations with Strong Cash Position
May 13 2026
seekingalpha
Avalo to Offer 19.73 Million Shares at $17.75 Each
May 06 2026
stocktwits
Avalo Therapeutics Prices Public Offering at $375M
May 06 2026
seekingalpha
Avalo Therapeutics Prices Public Offering at $17.75 per Share
May 06 2026
Newsfilter
Avalo Plans to Advance Abdakibart into Late-Stage Registration
May 05 2026
stocktwits
Avalo Therapeutics Reports FY EPS Beat Despite Revenue Decline
Mar 23 2026
seekingalpha
Avalo Therapeutics Completes Enrollment for AVTX-009 Trial
Feb 02 2026
Benzinga
Valvoline Analyst Starts Coverage Optimistically; Check Out Thursday's Top 5 Initiations
Dec 18 2025
Benzinga
Avalo Therapeutics Reveals Inducement Grants for New Hires in Accordance with Nasdaq Listing Rule 5635(c)(4)
Nov 17 2025
Newsfilter
Avalo Therapeutics Completes Patient Enrollment in Phase 2 LOTUS Trial for AVTX-009 Targeting Hidradenitis Suppurativa Treatment
Oct 29 2025
Newsfilter
DFAS's Assets May Indicate a 15% Profit Opportunity
Oct 02 2025
NASDAQ.COM
Avalo Therapeutics Strengthens Leadership Team with Important New Hires in Business Development and HR
Oct 01 2025
Newsfilter
Merus Shares Surge 38%; Check Out 20 Stocks Making Moves in Premarket Trading
Sep 29 2025
Benzinga
Avalo Therapeutics Names Kevin R. Lind to Its Board of Directors
Sep 22 2025
Newsfilter
HC Wainwright & Co. Reaffirms Buy Rating for Avalo Therapeutics, Increases Price Target to $25
Sep 17 2025
Benzinga
Top Analysts Recommend 3 Best Stocks to Purchase Now, 9/12/2025
Sep 12 2025
TipRanks
Show More News
